Analysis

Mid-day market update: Maxar technologies falls after Q1 results, Biolinerx shares climb

Midway through trading Tuesday, the Dow traded down 0.93% to 33,796.93 while the NASDAQ fell 2.6% to 13,530.71. The S&P also fell, dropping 1.4% to 4,134.15.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,472,120 cases with around 577,560 deaths. India confirmed a total of at least 20,282,830 cases and 222,400 deaths, while Brazil reported over 14,779,520 COVID-19 cases with 408,620 deaths. In total, there were at least 153,594,320 cases of COVID-19 worldwide with more than 3,214,790 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer staples shares slipped by just 0.2% on Tuesday. Meanwhile, top gainers in the sector included Farmer Bros. Co. FARM 5.7%, up 5%, and Reynolds Consumer Products Inc.  REYN 1.87% , up 3%.

In trading on Tuesday, information technology shares fell 2,6%.

Top Headline

Pfizer Inc.  PFE 0.18% reported stronger-than-expected results for its first quarter and boosted its FY21 forecast.

Pfizer reported quarterly earnings of $0.93 per share, beating analysts’ estimates of $0.78 per share. The company’s quarterly sales came in at $14.60 billion, versus expectations of $13.60 billion.

Pfizer raised FY21 adjusted EPS guidance from 3.10-$3.20 to $3.55-$3.65. The company also raised sales guidance from $59.4 billion-$61.4 billion to $70.5 billion-$72.5 billion.

Equities Trading UP

BioLineRx Ltd. BLRX 59.56% shares shot up 49% to $4.75 after the company announced positive top-line results from the GENESIS Phase 3 trial evaluating its lead clinical candidate, Motixafortide, in combination with granulocyte colony stimulating factor, the standard-of-care, for hematopoietic stem-cell mobilization for autologous bone marrow transplantation in multiple myeloma patients.

Shares of Neuronetics, Inc. STIM 35.54% got a boost, shooting 23% to $12.46 after the company reported Q1 results and raised its FY21 sales guidance.

Shineco, Inc. TYHT 23.95% shares were also up, gaining 16% to $13.85 after the company proposed to acquire 51% equity interests in Mayah Biological Holdings Limited.

Equities Trading DOWN

Sequential Brands Group, Inc. SQBG 35.46% shares tumbled 36% to $17.50. Sequential Brands Group’s 8-K showed the resignation of Chair William Sweedler.

Shares of Maxar Technologies Inc. MAXR 24% were down 25% to $29.44 after the company swung to a loss in the first quarter.

Image Sensing Systems, Inc. ISNS 26.49% was down, falling 32% to $7.64 following Q1 results. The company reported a decline in quarterly sales.

Commodities

In commodity news, oil traded up 1.3% to $65.32, while gold traded up 0.1% to $1,793.70.

Silver traded up 0.1% Tuesday to $26.97 while copper rose 0.2% to $4.5370.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 declined 1.37%, the Spanish Ibex Index fell 0.56% and the German DAX 30 dropped 2.48%. Meanwhile, the London’s FTSE 100 dropped 0.54%, French CAC 40 fell 0.87% and Italy’s FTSE MIB fell 1.87%.

The IHS Markit/CIPS UK manufacturing PMI was revised higher to 60.9 in April from a preliminary reading of 60.7, while consumer credit in the UK fell by GBP 0.5 billion in March. French government budget deficit increased to EUR 60.1 billion in the first quarter from EUR 52.5 billion in the year-ago period.

Economics

US trade deficit increased to $74.4 billion in March from a revised $70.5 billion gap in the earlier month. Exports surged 6.6%, while imports to the US climbed 6.3%.

The IBD/TIPP Economic Optimism Index fell by 3.5% to 54.4 in May.

US factory orders rose 1.1% in March following a revised 0.5% decline in February.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.